Price Volatility of Investment Securities
First written in FY2016. 10 of 30 entries say "Materialised", first in FY2017-Q1. Latest entry: FY2026.
Daio Paper moved to the "Worse" side of this theme in 2016, 3 years before the typical company in this theme (2019).
The whole theme swung hardest in 2019: 69 of 144 companies on the "Worse" side.
35 other companies' latest entry also says "Other".
- FY2026Investment securities increased through strategic share acquisitionsAnnual report
「Purchases of investment securities ¥26,616 million」
Investment securities increased from ¥21,382 million to ¥48,426 million through the acquisition of shares in Hokuetsu Corporation and other transactions, while the valuation difference on available-for-sale securities decreased from ¥5,696 million to ¥5,548 million. - FY2026-H1Valuation difference on available-for-sale securities increasedAnnual report
「Valuation difference on available-for-sale securities 5,696 6,883」
The valuation difference on available-for-sale securities increased from ¥5,696 million at the end of the previous consolidated fiscal year to ¥6,883 million. The company also recognized a gain on sale of investment securities of ¥295 million. - FY2025Valuation difference decreased, and a gain on sale was recognizedAnnual report
「The valuation difference on available-for-sale securities decreased from ¥6,749 million at the end of the previous consolidated fiscal year to ¥5,696 million. The company also recognized a gain on sale of investment securities of ¥1,530 million.」
The valuation difference on available-for-sale securities decreased from ¥6,749 million to ¥5,696 million. Investment securities were sold for ¥2,316 million, resulting in a gain on sale of ¥1,530 million. - FY2025-H1Valuation difference on available-for-sale securities decreased, and a gain on sale was recognizedAnnual report
「Valuation difference on available-for-sale securities 6,749 5,322」
The valuation difference on available-for-sale securities decreased from ¥6,749 million at the end of the previous consolidated fiscal year to ¥5,322 million. The company also recognized a gain on sale of investment securities of ¥1,530 million. - FY2024Valuation difference on available-for-sale securities increased, and shares held were soldAnnual report
「Valuation difference on available-for-sale securities 6,749」
The valuation difference on available-for-sale securities increased from ¥3,968 million at the end of the previous fiscal year to ¥6,749 million. The company also sold shares, including cross-shareholdings, for ¥4,496 million and recognized a gain on sale of ¥3,105 million. - FY2024-Q3Further increase in the valuation difference on available-for-sale securitiesAnnual report
「Valuation difference on available-for-sale securities 3,968 4,730」
The valuation difference on available-for-sale securities increased from ¥3,968 million at the end of the previous consolidated fiscal year to ¥4,730 million, and fluctuations in the prices of securities held affected net assets. - FY2024-Q2Valuation difference on available-for-sale securities increasedAnnual report
「Valuation difference on available-for-sale securities 3,968 4,248」
The valuation difference on available-for-sale securities increased from ¥3,968 million at the end of the previous consolidated fiscal year to ¥4,248 million. - FY2024-Q1MaterialisedAnnual report
「Valuation difference on available-for-sale securities △ 810 △ 340」
The valuation difference on available-for-sale securities decreased by ¥340 million, and fluctuations in investment security prices affected comprehensive income and net assets. - FY2023-Q3WorsenedAnnual report
「Valuation difference on available-for-sale securities 3,445 3,086」
The valuation difference on available-for-sale securities decreased from ¥3,445 million at the end of the previous consolidated fiscal year to ¥3,086 million, and fluctuations in the prices of securities held continued to affect net assets. - FY2023-Q2WorsenedAnnual report
「Valuation difference on available-for-sale securities 3,445 2,727」
The valuation difference on available-for-sale securities decreased from ¥3,445 million at the end of the previous consolidated fiscal year to ¥2,727 million, and fluctuations in the prices of securities held affected net assets. - FY2023-Q1WorsenedAnnual report
「Valuation difference on available-for-sale securities 3,445 2,625」
The valuation difference on available-for-sale securities decreased from ¥3,445 million at the end of the previous consolidated fiscal year to ¥2,625 million, and fluctuations in the prices of securities held affected net assets. - FY2022MitigatedAnnual report
「Fiscal year ended 31 March 2022 There are no applicable matters.」
No impairment loss on investment securities occurred in the current year, eliminating the loss recorded in the previous year of ¥213 million. The company is also responding to the impact of price fluctuations in line with its policy of reducing cross-shareholdings. - FY2021WorsenedAnnual report
「During the current consolidated fiscal year, the company recognized impairment losses of ¥213 million on securities, all of which related to other securities.」
Impairment losses on investment securities increased from ¥19 million in the previous year to ¥213 million. Meanwhile, the valuation difference on available-for-sale securities recovered from a negative amount in the previous year to ¥4,226 million, with the impact varying by item. - FY2021-Q3MitigatedAnnual report
「Valuation difference on available-for-sale securities △ 3,848 146」
The valuation difference on available-for-sale securities changed from negative ¥3,848 million in the same period of the previous year to ¥146 million in the current period, reducing the adverse impact of fluctuations in the prices of securities held on net assets compared with the previous period. - FY2021-Q2WorsenedAnnual report
「Impairment loss on investment securities 17 356」
Impairment losses on investment securities increased from ¥17 million in the same period of the previous year to ¥356 million, and losses arising from price fluctuations increased. - FY2021-Q1WorsenedAnnual report
「Impairment loss on investment securities 17 335」
Impairment losses on investment securities for the first quarter of the current consolidated cumulative period were ¥335 million, up from ¥17 million in the same period of the previous year. - FY2020WorsenedAnnual report
「Valuation difference on available-for-sale securities △6,341」
The valuation difference on available-for-sale securities decreased by ¥6,341 million due to fluctuations in the prices of shares held, increasing the impact on net assets. Meanwhile, the company sold ¥7,700 million of investment securities and recognized a gain on sale of ¥6,778 million. - FY2020-Q3WorsenedAnnual report
「Valuation difference on available-for-sale securities △ 3,848」
The valuation difference on available-for-sale securities changed from negative ¥2,773 million in the same quarter of the previous year to negative ¥3,848 million, and fluctuations in the prices of securities held had a greater impact on comprehensive income and net assets. - FY2020-Q2WorsenedAnnual report
「Valuation difference on available-for-sale securities 2,441 △ 5,209」
The valuation difference on available-for-sale securities changed from an increase of ¥2,441 million in the same period of the previous year to a decrease of ¥5,209 million in the current period, and fluctuations in the prices of securities held had a greater impact on net assets. - FY2020-Q1MaterialisedAnnual report
「Valuation difference on available-for-sale securities △ 334」
The valuation difference on available-for-sale securities decreased by ¥334 million, and fluctuations in the prices of securities held affected comprehensive income and net assets. - FY2019-Q3WorsenedAnnual report
「Valuation difference on available-for-sale securities △ 2,773」
The valuation difference on available-for-sale securities declined due to a fall in the market value of shares held, and fluctuations in investment security prices affected net assets and the equity ratio. - FY2018MaterialisedAnnual report
「During the current consolidated fiscal year, the company recognized impairment losses of ¥24 million on securities, comprising ¥14 million on shares of affiliated companies and ¥10 million on other securities.」
The company recognized ¥24 million in impairment losses on investment securities and other securities. It also recognized a gain on the sale of investment securities of ¥5,754 million. - FY2018-Q3MaterialisedAnnual report
「Impairment loss on investment securities ¥116 million」
The company recognized an impairment loss on investment securities of ¥116 million during the third quarter of the current consolidated cumulative period, resulting in a loss from fluctuations in investment security prices. - FY2018-Q2MaterialisedAnnual report
「Impairment loss on investment securities 113」
The company recognized an impairment loss on investment securities of ¥113 million during the second quarter of the current consolidated cumulative period, resulting in a loss from fluctuations in investment security prices. - FY2018-Q1MaterialisedAnnual report
「Impairment loss on investment securities ¥104 million」
The company recognized an impairment loss on investment securities of ¥104 million during the first quarter of the current consolidated cumulative period, resulting in a loss from fluctuations in investment security prices. - FY2017MaterialisedAnnual report
「Impairment loss on investment securities ¥163 million」
The company recognized an impairment loss on investment securities of ¥163 million during the current consolidated fiscal year, disclosing a loss arising from fluctuations in investment security prices. - FY2017-Q3MaterialisedAnnual report
「Impairment loss on investment securities ¥164 million」
The company recognized an impairment loss on investment securities of ¥164 million during the third quarter of the current consolidated cumulative period. - FY2017-Q2MaterialisedAnnual report
「Impairment loss on investment securities ¥164 million」
The company recognized an impairment loss on investment securities of ¥164 million during the second quarter of the current consolidated cumulative period. - FY2017-Q1MaterialisedAnnual report
「Impairment loss on investment securities ¥164 million」
The company recognized an impairment loss on investment securities of ¥164 million during the first quarter, resulting in a loss from changes in the valuation of investment securities. - FY2016First statedAnnual report
「Other securities with market prices are measured at fair value based on market prices and other information as of the balance sheet date. Accordingly, the share price as of that date may affect the financial position and operating results of the Group.」
The company discloses the risk of share price fluctuations associated with holding investment securities with market prices.